1Brosens ZA.Endometriosis:a disease because it is characterized by bleeding.Am J Obstet Gynecol,1997,176:263.
2Berkanoglu M,Arici A.Immunology and endometriosis.American Journal of Reprouctive Immunology,2003,50(1):48.
3Stern RC,Dash R,Bentley RC et al.Malignancy in endometriosis:frequency and comprision of ovarian and extra-ovarian types.Int J Gynecol Pathol,2001,20(2):133.
6Ryan IP, Schriock ED, Taylor RN. Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro [J]. J Clin Endocrinol Metab, 1994 , 78: 642.
7Kettel LM, Murphy AA, Morales A J, et al. Treatment of endometriosis with the antiprogesterone mifepristone (RU486)[J]. Fertil Steril, 1996, 65:23.
8Donnez J, Smoes P, Gillerot S, et al. Vascular endothelial growth factor (VEGF) in endometriosis [J].Hum Reprod, 1998, 13:1686.
9Khan KN, Masuzaki H, Fujishita A, et al. Immunoexpression of hepatocyte growth factor and c-Met receptor in the eutopic endometrium predicts the activity of ectopic endometrium[J]. Fertil Steril, 2003,79:173.
10Classen-Linke I, Alfer J, Krusche CA, et al. Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture[J]. Steroids, 2000, 65:763.
